Stem Cell Translpantation in Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2012

Conditions
Multiple Myeloma
Interventions
PROCEDURE

HLA Matched allogeneic transplant

Trial Locations (24)

1090

Medizinische Universität Wien, Vienna

2100

Rigshospitalet, Copenhagen

2730

Herlev Hospital, Herlev

20133

University of Milano, Milan

33521

Tampere University Hospital, Tampere

34295

CHU Lapeyronie, Montpellier

41100

Uni. Modena, Policlinico, Modena

50134

Ospedale di Careggi, Florence

69120

University of Heidelberg, Heidelberg

71013

IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo

75185

University Hospital, Uppsala

95100

Ospedale Ferrarotto, Catania

Unknown

Québec

Tromsø

Trondheim

Stockholm

00029

Helsinki University Central Hospital, Helsinki

52 20521

Turku University, Turku

04103

University of Leipzig, Leipzig

0027

Rikshospitalet, Oslo

413 45

Sahlgrenska University Hospital, Gothenburg

141 86

Huddinge University Hospital, Huddinge

06260

University Faculty of Medicine, Ankara

SM2 5PT

Royal Marsden Hospital, London

All Listed Sponsors
lead

European Society for Blood and Marrow Transplantation

NETWORK

NCT05082675 - Stem Cell Translpantation in Multiple Myeloma | Biotech Hunter | Biotech Hunter